A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results
-
Published:2024-01
Issue:
Volume:67
Page:102404
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Schoergenhofer ChristianORCID,
Gelbenegger Georg,
Hasanacevic Dzenita,
Schöner Léa,
Steiner Margarete M.,
Firbas Christa,
Buchtele Nina,
Derhaschnig Ulla,
Tanzmann Andreas,
Model Nina,
Larcher-Senn Julian,
Drost Manuel,
Eibl Martha M.,
Roetzer Andreas,
Jilma Bernd
Reference30 articles.
1. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention;Davis;N Engl J Med,1980
2. Understanding toxic shock syndrome;Burnham;Intensive Care Med,2015
3. Menstrual toxic shock syndrome: case report and systematic review of the literature;Berger;Lancet Infect Dis,2019
4. Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics;DeVries;PLoS One,2011
5. Association of characteristics of tampon use with menstrual toxic shock syndrome in France;Billon;eClinicalMedicine,2020